BEAM
Price
$17.09
Change
+$0.38 (+2.27%)
Updated
Jun 24, 11:57 AM (EDT)
Capitalization
1.68B
49 days until earnings call
CRSP
Price
$46.47
Change
+$0.92 (+2.02%)
Updated
Jun 24, 10:58 AM (EDT)
Capitalization
3.93B
48 days until earnings call
Interact to see
Advertisement

BEAM vs CRSP

Header iconBEAM vs CRSP Comparison
Open Charts BEAM vs CRSPBanner chart's image
Beam Therapeutics
Price$17.09
Change+$0.38 (+2.27%)
Volume$555
Capitalization1.68B
CRISPR Therapeutics AG
Price$46.47
Change+$0.92 (+2.02%)
Volume$366
Capitalization3.93B
BEAM vs CRSP Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CRSP commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CRSP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2025
Stock price -- (BEAM: $16.71 vs. CRSP: $45.55)
Brand notoriety: BEAM and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. CRSP: 99%
Market capitalization -- BEAM: $1.68B vs. CRSP: $3.93B
BEAM [@Biotechnology] is valued at $1.68B. CRSP’s [@Biotechnology] market capitalization is $3.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and CRSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while CRSP’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 6 bearish.
  • CRSP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +0.54% price change this week, while CRSP (@Biotechnology) price change was +9.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.60%. For the same industry, the average monthly price growth was +34.85%, and the average quarterly price growth was +16.41%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+3.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.93B) has a higher market cap than BEAM($1.68B). CRSP YTD gains are higher at: 15.727 vs. BEAM (-32.621). BEAM has higher annual earnings (EBITDA): -399.03M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. BEAM (1.22B). BEAM has less debt than CRSP: BEAM (158M) vs CRSP (219M). BEAM has higher revenues than CRSP: BEAM (63.6M) vs CRSP (35M).
BEAMCRSPBEAM / CRSP
Capitalization1.68B3.93B43%
EBITDA-399.03M-455.24M88%
Gain YTD-32.62115.727-207%
P/E RatioN/AN/A-
Revenue63.6M35M182%
Total Cash1.22B1.86B66%
Total Debt158M219M72%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCRSP
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 13 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DALI25.720.28
+1.08%
First Trust Dorsey Wright DALI 1 ETF
SPEU47.120.43
+0.91%
SPDR® Portfolio Europe ETF
GVI106.260.24
+0.23%
iShares Intermediate Govt/Crdt Bd ETF
OIA5.65-0.02
-0.35%
INVESCO Municipal Income OPPORTUNITIES TRUST
SATO17.34-0.19
-1.10%
Invesco Alerian Galaxy Crypto Eco ETF